Rakovina Therapeutics Announces Initial Drug Candidates from Deep Docking AI Molecule Discovery Platform
Company to present initial results of this research at the Society for Neuro-Oncology Annual Meeting in November VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company committed to… Read More




